Differential Diagnosis of Disorders of Sex Development (DSD) by Molecular Genetic Analyses
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Sex determination and differentiation require the balanced and sequential activation of transcription factors, signaling molecules, hormones and their receptors. Disorders of sex development (DSD) have heterogeneous groups of etiologies caused by mutations or deletions of genes involved in sex development. The DSD is categorized into 46, XX DSD, 46,XY DSD, sex chromosome DSD, ovotesticular DSD, and 46,XX testicular DSD. Precise diagnosis is essential for sex assignment, surgical correction of external genitalia,prevention of gonadal tumors, psychiatric support, and genetic counseling. The increased genetic knowledge in the field has opened up new diagnostic possibilities. The first line genetic testing for DSD is the assessment of the karyotype and the SRY gene. The follow-up genetic tests are performed for confirmatory diagnosis; the evaluation of copy number variants by array comparative genomic hybridization (CGH),direct sequencing of a specific gene, and functional analyses of mutations. A lot of genes can be analyzed by molecular laboratories and the number of available genes is growing. DNA analyses should be done under clinical assessment on the basis of family history, prenatal history, physical findings focused on external genitalia, endocrinologic data, and radiologic findings. Genetic counseling is essential to help patients and their families understand the disease status and the risk for recurrence in future pregnancies,and participate in the process of sex assignment. Children with DSD should be managed with a multidisciplinary team, including pediatric endocrinology, molecular genetics, cytogenetics, neonatology, urology, and psychiatry.
Abstract
Sex determination and differentiation require the balanced and sequential activation of transcription factors, signaling molecules, hormones and their receptors. Disorders of sex development (DSD) have heterogeneous groups of etiologies caused by mutations or deletions of genes involved in sex development. The DSD is categorized into 46, XX DSD, 46,XY DSD, sex chromosome DSD, ovotesticular DSD, and 46,XX testicular DSD. Precise diagnosis is essential for sex assignment, surgical correction of external genitalia,prevention of gonadal tumors, psychiatric support, and genetic counseling. The increased genetic knowledge in the field has opened up new diagnostic possibilities. The first line genetic testing for DSD is the assessment of the karyotype and the SRY gene. The follow-up genetic tests are performed for confirmatory diagnosis; the evaluation of copy number variants by array comparative genomic hybridization (CGH),direct sequencing of a specific gene, and functional analyses of mutations. A lot of genes can be analyzed by molecular laboratories and the number of available genes is growing. DNA analyses should be done under clinical assessment on the basis of family history, prenatal history, physical findings focused on external genitalia, endocrinologic data, and radiologic findings. Genetic counseling is essential to help patients and their families understand the disease status and the risk for recurrence in future pregnancies,and participate in the process of sex assignment. Children with DSD should be managed with a multidisciplinary team, including pediatric endocrinology, molecular genetics, cytogenetics, neonatology, urology, and psychiatry.
참고문헌 (25)
- Hughes IA, "Consequences of the ESPE", LWPES guidelines for diagnosis and treatment of disorders of sex development, 2007, pp.21, 351~365
- Lee PA, "International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex", Pediatrics, 118, pp.e488~e500 (2006)
- Blecher SR, "Genetics of sexual development: a new paradigm", Am J Med Genet A, 143A, pp.3054~3068 (2007)
- Hughes IA, "Intersex", BJU Int, 90, pp.769~776 (2002)
- MacLaughlin DT, "Sex determination and differentiation", N Engl J Med, 350, pp.367~378 (2004)
- Shen WH, "Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: a link to the sex determination cascade", Cell, 77, pp.651~661 (1994)
- Parker KL, "Steroidogenic factor 1: a key determinant of endocrine development and function", Endocr Rev, 18, pp.361~377 (1997)
- Nachtigal MW, "Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression", Cell, 93, pp.445~454 (1998)
- Kucinskas L, "Human male sex determination and sexual differentiation: pathways, molecular interactions and genetic disorders", Medicina (Kaunas), 41, pp.633~640 (2005)
- Bardoni B, "A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal", Nat Genet, 7, pp.497~501 (1994)
- Lambert SM, "A practical approach to ambiguous genitalia in the newborn period", Urol Clin North Am, 37, pp.195~205 (2010)
- Muscatelli F, "Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism", Nature, 372, pp.672~676 (1994)
- Choi JH, "Functional effects of DAX-1 mutations identified in patients with X-linked adrenal hypoplasia congenita", Metabolism, 60, pp.1545~1550 (2011)
- Merke DP, "Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene", N Engl J Med, 340, pp.1248~1252 (1999)
- Goodfellow PN, "DAX-1, an 'antitestis' gene", Cell Mol Life Sci, 55, pp.857~863 (1999)
- Kim JM, "High allele frequency of the p.Q258X mutation and identification of a novel mis-splicing mutation in the STAR gene in Korean patients with congenital lipoid adrenal hyperplasia", Eur J Endocrinol, 165, pp.771~778 (2011)
- 유한욱, "Molecular analysis of the AR and SRD5A2 genes in patients with 46,XY disorders of sex development", JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 21, pp.545~553, Freund Pub. House
- Ottolenghi C, "Foxl2 is required for commitment to ovary differentiation", Hum Mol Genet, 14, pp.2053~2062 (2005)
- Nabhan ZM, "Disorders of sex development", Curr Opin Obstet Gynecol, 19, pp.440~445 (2007)
- Parisi MA, "A Gender Assessment Team: experience with 250 patients over a period of 25 years", Genet Med, 9, pp.348~357 (2007)
- White S, "Copy number variation in patients with disorders of sex development due to 46,XY gonadal dysgenesis", PLoS One, 6, pp.e17793~ (2011)
- Ogilvy-Stuart AL, "Early assessment of ambiguous genitalia", Arch Dis Child, 89, pp.401~407 (2004)
- Morel Y, "Aetiological diagnosis of male sex ambiguity: a collaborative study", Eur J Pediatr, 161, pp.49~59 (2002)
- Barbaro M, "Disorders of sex development", Semin Fetal Neonatal Med, 16, pp.119~127 (2011)
- Migeon CJ, "Human sex differentiation: from transcription factors to gender", Horm Res, 53, pp.111~119 (2000)